Media – Blog
November 3, 2021
The Federal Reserve met over the past two days to review its stance on monetary policy, and it has provided specific details on plans to taper its bond purchase program over the next few quarters. Since March of 2020, the central bank has been buying $120 billion of assets each
Read more
November 1, 2021
Co-authored by: Alexander Goldman In June of 2019 the House Committee on the Judiciary launched an investigation into whether Silicon Valley had fallen under the grip of a few large gatekeepers that have come to control key areas of e-commerce. A sixteen-month examination of key players’ market dominance, primarily focusing
Read more
October 14, 2021
While most major integrated oil and gas companies have expressed alignment with the Paris Agreement, efforts made by U.S. players to address climate change with a transition to more renewable energy sources have fallen short in comparison to their European counterparts. As some drag their feet on sustainability efforts, governments,
Read more
June 30, 2021
As the US economy emerges from the severe economic dislocation of the pandemic, early indications point to a strong recovery in 2021, with GDP growth poised to exceed 6% based on annualized first quarter data. Expansionary fiscal and monetary policy, healthier household balance sheets, and pent-up consumer demand are likely
Read more
November 5, 2020
The old adage in corporate debt financing is “The best time to borrow is when you need it the least.” But the concept of timing when it comes to debt financing can take many different forms. This blog post intends to address some of the potential timing issues around debt
Read more
November 2, 2020
With 48 potential SARS-CoV-2 vaccines now undergoing clinical trials on humans, there’s mounting hope that one or more will be available in 2021. But many unknowns remain, especially regarding potential financial implications for the pharmaceutical companies that produce them. Timing of their arrival, manufacturing capacity, distribution, levels of potential government
Read more
August 25, 2020
Biotech companies have taken center stage during the pandemic of 2020. Between the many vaccine initiatives and even more numerous investments in testing and new Covid-19 therapies, money is flooding into the sector at a record rate. Biotechs raised more than $6 billion in initial public offerings in just the
Read more
July 3, 2020
States across the U.S. set multiple single day records for new COVID-19 cases this past week. On June 27th, Florida reported 9,500 new cases, breaking its own record for daily new cases, which it set just a day earlier. Driven primarily by Southern and Southwestern states, the surge has forced
Read more
June 18, 2020
The global tech supply chain is about to be turned upside down. Tensions between the U.S. and China, heightened in a two-year-long trade war, were already instigating conversations regarding relocating and reconstructing the supply chain. Now that the coronavirus has further exposed the limited geographic diversity and concentration levels in
Read more
June 11, 2020
Watch the webcast: Click the above video webcast by Capital Advisors Group EVP Stefan Spazek. Some managers of emerging growth companies who took out loans prior to the pandemic may now be confronting the prospect of violating covenants written into their debt agreements. Debt covenants are financial and/or performance-based requirements
Read more